View Post

$24 Million in Grants Will Help End the HIV Epidemic

In COVID-19, Latest News by Precision Vaccinations

Gilead Sciences, Inc. today announced $24 million in new grants that will help reduce health disparities, improve access to quality healthcare, advance medical education and support local communities most impacted by the HIV epidemic and COVID-19 pandemic. 
Gilead confirmed the Zeroing In: Ending the HIV Epidemic program will support 116 organizations in 41 countries. 
The funding recipients will focus on advancing at least one of three focus areas: Comprehensive HIV Innovation, Digital Health Innovation, and Community Outreach and Education.